Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00092
Full Text
Open PDFAbstract
Available in full text
Date
March 29, 2018
Authors
Publisher
Frontiers Media SA